Based on the progress and results obtained in the first nine months of 2024, BioPorto maintains its financial guidance for 2024, as most recently described in its Interim Report for the Second Quarter ...
Naomi Beckman Straus; General Counsel & Corporate Secretary ... including adjusted EBITDA, adjusted EBITDA margin, net debt and free cash flow. We use non-GAAP measures in some of our financial ...
The CyBio FeliX, a benchtop instrument for automated liquid handling tasks, was used to automate the HaloPlex Target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback